论文信息 - Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials - 字舞流文

Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials

T. Hangartner | M. Kabra | A. Mehta | A. Bavdekar | D. Hughes | D. Elstein | A. Zimran | Nan Wang | P. Giraldo | E. Crombez | D. Gonzalez | E. Lukina | I. Kisinovsky